Skip to main content
Hit enter to search or ESC to close
Close Search
AccessDx Laboratory
  • Order Testing
Menu
  • Providers
    • Testing Offerings
      • Pharmacogenomics (PGx)
      • Hereditary Cancer
      • Infectious Disease
    • Programs
      • Medication Safety Program for LTPACs
  • Patients & Families
  • About
    • Contact Us
    • Newsroom
    • Events
    • Careers
  • Provider Portal
  • Patient Portal
  • Order Testing
  • Providers
    • Testing Offerings
      • Pharmacogenomics (PGx)
      • Hereditary Cancer
      • Infectious Disease
    • Programs
      • Medication Safety Program for LTPACs
  • Patients & Families
  • About
    • Contact Us
    • Newsroom
    • Events
    • Careers
  • Provider Portal
  • Patient Portal
  • twitter
  • x-twitter
  • linkedin
Tag

Press Release

InterVenn Biosciences Partners with Aranscia
News

InterVenn Biosciences Partners with Aranscia

AccessDx PGx Profile Drives Greater Precision in Medication Optimization
News

AccessDx PGx Profile Drives Greater Precision in Medication Optimization

Recent Posts

  • InterVenn Biosciences Partners with Aranscia
  • PGxperts™ Bytes: Medication Safety, Survey Readiness, and the Role of PGx in Long-Term Care
  • PGxperts™ Bytes: The Case for DPYD Testing
  • DPYD Safety Update: Reducing the Risk of Critical or Fatal Chemotherapy Side Effects
  • AccessDx Lab to Exhibit at ASCP 2025

Recent Comments

    Popular Posts

    • Pharmacogenomic Testing as a Preventive Approach to Tardive Dyskinesia Risk Reduction and Management May 5, 2025
    • AccessDx Lab to Exhibit at the 2024 PointClickCare SUMMIT January 24, 2025
    • AccessDx Lab to Exhibit at the 2024 Psych Congress October 1, 2024

    Recent Posts

    • InterVenn Biosciences Partners with Aranscia January 7, 2026
    • PGxperts™ Bytes: Medication Safety, Survey Readiness, and the Role of PGx in Long-Term Care January 6, 2026
    • PGxperts™ Bytes: The Case for DPYD Testing November 25, 2025

    CLIA-certified, CAP-accredited, NYSDOH-approved, and fully compliant with HIPAA and FDA standards.

    Legal

    Address

    AccessDx Laboratory, LLC
    4035 Willowbend Blvd. Suite 400
    Houston, TX 77025

    Connect

    T: 888-958-2298
    E: [email protected]

    © 2026 AccessDx Laboratory.

    • linkedin